Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Medical - Devices

Healthcare
$1.20 -6.72%

-$0.09 today

Market cap
$50.65M
Beta
-1.23
P/E (TTM)
-1.3
EPS (TTM)
-$0.94
52W Low $0.76High $7.26

Volume 0.02M

Average 0.37M

BDMD Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Baird Medical Investment Holdings LimitedNASDAQ: BDMD

Net Margin · Q4 FY2025 · quarter ended Dec 2025

Net margin narrows to -109.6%

Net margin was -109.6% in Q4 FY2025, down 143.6 pp from a year earlier. Over 3 fiscal years it narrowed by 156.9 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
-109.6%— QoQ
Last fiscal yearDec 2025
-121.0%-154.7 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-143.6 pp——
1 year-154.7 pp——
3 years-156.9 pp——
5 years——
10 years——

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-121.0%
Year-over-year change
-154.7pp

Net Margin vs competitors

How BDMD compares with its peers on the latest reported figures

  • BDMD's FY2025 net margin of -121.0% is the lowest of the 3 companies compared; the peer median is -38.7%.
  • Its year-over-year change of -154.7 pp is the lowest of 3, against a peer median of +11.6 pp.
  • Over three fiscal years its change of -156.9 pp compares with a peer median of +172.9 pp.
BDMD Competitors Peer median
Net Margin for BDMD and competitors
Company Period LTM level YoY 3-year change
BDSXBiodesix, Inc.LTM Mar 2026-33.3% +21.0 pp+131.4 pp
ECORelectroCore, Inc.LTM Mar 2026-44.1% +2.2 pp+214.3 pp
BDMDBaird Medical Investment Holdings LimitedFY2025-121.0% -154.7 pp-156.9 pp
OKUROnKure Therapeutics, Inc.FY2025— ——
Peer median (excluding BDMD) -38.7%+11.6 pp+172.9 pp

Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue27.72M35.09M31.46M37.04M22.54M
Cost of Revenue4.54M7.05M4.23M4.38M3.65M
Gross Profit23.18M28.04M27.23M32.65M18.88M
Gross Margin83.6%79.9%86.6%88.2%83.8%
Research & Development1.04M3.86M4.27M6.17M20.13M
Selling, General & Admin10.22M10.55M11.09M9.96M24.38M
Operating Expenses9.76M13.03M15.37M17.34M44.42M
Depreciation & Amortization1.4M1.47M1.01M1.51M1.1M
EBITDA14.16M16.29M12.88M16.17M(24.53M)
EBITDA Margin51.1%46.4%40.9%43.7%-108.9%
Operating Income11.92M13.63M11.86M15.32M(25.54M)
Operating Margin43.0%38.8%37.7%41.4%-113.3%
Interest Income2.33K8.55K03930
Interest Expense153.92K299.27K284.27K576.75K737.37K
Other Income / Expenses688.35K890.15K497.48K(1.23M)(837.57K)
Income Before Tax12.61M14.52M12.36M14.09M(26.37M)
Pre-Tax Margin45.5%41.4%39.3%38.0%-117.0%
Income Tax Expense2.42M1.75M1.7M1.49M1.17M
Net Income11.68M12.57M10.55M12.45M(27.28M)
Net Margin42.1%35.8%33.5%33.6%-121.0%
EPS (Basic)(0.02)0.020.410.49(0.98)
EPS (Diluted)(0.02)0.020.410.49(0.98)
Weighted Avg Shares7.19M6.29M7.58M25.56M27.79M
Weighted Avg Shares (Diluted)7.19M7.19M7.58M25.63M27.79M

Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Intrinsic Alpha fair value

Locked

Current Price

$1.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.